At Sygnature Discovery, we recognise that biophysics is a valuable component of drug discovery programs. We have invested in the establishment of scientific excellence and industry leading technology to grow our biophysics capability and to imbed the value of its use across our scientific teams.
Our biophysics platform provides techniques that can deliver hit finding approaches for fragment-based lead discovery and a full mechanistic, structural, kinetic, and thermodynamic profile for your novel compounds.
We have dedicated biophysicists who can support your integrated drug discovery program with a suite of high-end technology platforms that can deliver a complete biophysical assessment of your compounds of interest.
In addition to the range of in-house biophysics platforms, Sygnature has selected trusted strategic alliance partners to augment our biophysics capabilities, providing you with access to discovery excellence.